【AstraZeneca】【ONC】Director, New Modality, オンコロジー事業本部
AstraZeneca
大阪市, Unknown, 日本
Contract
Competitive
OfficeDirector
English follows Japanese
ポジション概要
日本における新規モダリティ製品（細胞治療、放射性複合体（RC））のコマーシャル戦略、事業成立性評価、市場形成、Go-to-Marketモデル構築をリードするシニアポジションです。
本ポジションは、Japan Leadership Team（JLT/ 日本の経営陣） レベルで重要なコマーシャル意思決定に関与し、New Modality Strategy Lead（R&D） をはじめとする社内の主要ステークホルダーと連携しながら、戦略的方向性と商業的実現可能性を結びつけ、日本市場における持続的な事業成功を推進します。
Position Summary
We are seeking a Senior Commercial Leader, New Modality to lead commercial strategy, business viability assessment, market shaping, and go-to-market model development for innovative new modality products in Japan, including Cell Therapy, Radioconjugates (RC), and other assigned modalities.
This is a senior leadership role that will shape key commercial decisions at the Japan Leadership Team (JLT) level. The successful candidate will work closely with cross-functional leaders, including the New Modality Strategy Lead (R&D), to ensure that strategic direction and commercial feasibility are aligned and translated into strong business outcomes.
主な業務内容
複数プロジェクトにまたがる事業成立性評価をリードし、関係部門と連携し、製品別・適応症別のP&L、キャッシュフロー、NPV分析を含む財務モデルの構築を主導します。価格戦略、供給モデル、COGSなどを踏まえたシナリオ分析を通じて、収益性目標の設定や事業改善レバーの特定を行います。
また、適応症横断・BU横断での市場形成戦略を統括し、患者アクセス戦略、治療実施施設ネットワーク設計、顧客・患者インサイトの創出、外部ステークホルダーとの連携、Medical部門と協働したエビデンスに基づくバリュープロポジション構築を推進します。
さらに、細胞治療およびRCにおける日本市場最適化型Go-to-Marketモデルの設計・構築を担い、複数適応症にわたる上市戦略およびライフサイクル戦略をリードします。営業体制設計、アカウントマネジメント、デジタル施策、患者支援プログラムなど、上市に必要なコマーシャル機能要件の定義も重要な役割です。
加えて、New Modality Strategy Lead（R&D） の戦略的パートナーとして、コマーシャル戦略、事業計画、全社レベルの意思決定の整合性を担保し、上市後オペレーティングモデル設計や中長期的な事業持続性にも貢献します。
Key Responsibilities
In this role, you will lead cross-project business viability assessments and guide the development of product- and indication-specific financial models, including P&L, cash flow, and NPV analyses, to support critical business decisions. You will define profitability targets and identify business improvement levers through scenario planning covering pricing, supply models, and cost of goods.
You will also oversee market shaping strategies across indications and business units, including patient access planning, treatment site network strategy, customer and patient insights, external stakeholder engagement, and evidence-based value proposition development in partnership with Medical and other functions.
In addition, you will design and implement Japan-optimized go-to-market models for Cell Therapy and RC, lead launch and lifecycle commercial strategy across multiple indications, and define the commercial capabilities required for successful launch readiness. This includes field force design, account management approaches, digital engagement, and patient support programs.
As a strategic partner to the New Modality Strategy Lead (R&D), you will ensure alignment across commercial strategy, business case development, and enterprise decision-making, while contributing to post-launch operating model design and long-term business sustainability.
必須要件/Requirements
経験
Experiences
スキル&知識
Skills& Knowledge
学歴
学位
尚可： 生命科学、薬学、MBA、または関連分野における修士号以上の学位
Educational Background
Bachelor's degree required.
Advanced degree preferred (Life Sciences, Pharmacy, MBA, or related field)
キャリアレベル / Career Level
F
勤務地 / Location
Osaka or Tokyo
Date Posted
17-6月-2026Closing Date
AstraZeneca embraces diversity and equality of opportunity. We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills. We believe that the more inclusive we are, the better our work will be. We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics. We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorization and employment eligibility verification requirements.